VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ESMO 2019 | MSI-H status in advanced G/GEJ

Kohei Shitara, MD, National Cancer Center Hospital, Kashiwa, Japan, outlines the importance of microsatellite instability-high (MSI-H) status in the treatment of patients with advanced gastric and gastroesophageal junction cancer. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter